Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations

TW202633889APending Publication Date: 2026-08-16BRISTOL MYERS SQUIBB CO +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144144
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-04-11
Filing Date
2020-04-10
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072981_001
    Figure TWG2TA001072981_001
  • Figure TWG2TA001072981_002
    Figure TWG2TA001072981_002
  • Figure TWG2TA001072981_003
    Figure TWG2TA001072981_003
Patent Text Reader

Abstract

This invention relates to solid amorphous dispersions comprising Compound (I) having the formula and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability.
Need to check novelty before this filing date? Find Prior Art